Massimo Derenzini
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Ribosome biogenesis rate, a parameter of sensitivity to chemotherapeutic drugs inhibiting rRNA synthesis.
Journal: Oncology reviews
Published: November 05, 2025
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate.
Journal: Oncotarget
Published: March 23, 2016
Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?
Journal: Oncotarget
Published: June 29, 2015
Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate.
Journal: Oncogene
Published: November 18, 2014
Chromatin structure in situ: the contribution of DNA ultrastructural cytochemistry.
Journal: European journal of histochemistry : EJH
Published: September 17, 2013
The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective.
Journal: OncoTargets and therapy
Published: July 27, 2013
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer.
Journal: Oncogene
Published: May 28, 2013
Ribosome biogenesis and control of cell proliferation: p53 is not alone.
Journal: Cancer research
Published: January 28, 2012
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury.
Journal: TheScientificWorldJournal
Published: November 01, 2011
Last Updated: 09/26/2026